Latest filing published 22 Feb 2018 for Navidea Biopharmaceuticals, INC..
Insider track record
Mark I. Greene: trading record in brief
This profile gathers the share dealings of Mark I. Greene in Navidea Biopharmaceuticals, Inc. In total, 6 filings cover trades dated from 20 April 2016 to 20 February 2018.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 22 February 2018 came the latest disclosure, a share grant in Navidea Biopharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark I. Greene
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001437749-18-003134:0
- 50,000 shares0Common StockSEC:0001437749-17-012098:0
- 16,406 shares@ US$0.6448.0% of flowCommon StockSEC:0001144204-17-001745:0
- 11,413 shares@ US$0.8743.6% of flowCommon StockSEC:0001144204-16-128488:0
- 28,000 shares0Common StockSEC:0001144204-16-097838:0
- 1,425 shares@ US$1.378.3% of flowCommon StockSEC:0001144204-16-097838:1
6 of 6 declarations